BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11225603)

  • 1. Clinical and biological features of acute myeloid leukaemia occurring as second malignancy: GIMEMA archive of adult acute leukaemia.
    Pagana L; Pulsoni A; Tosti ME; Avvisati G; Mele L; Mele M; Martino B; Visani G; Cerri R; Di Bona E; Invernizzi R; Nosari A; Clavio M; Allione B; Coser P; Candoni A; Levis A; Camera A; Melillo L; Leone G; Mandelli F;
    Br J Haematol; 2001 Jan; 112(1):109-17. PubMed ID: 11225603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute lymphoblastic leukaemia occurring as second malignancy: report of the GIMEMA archive of adult acute leukaemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
    Pagano L; Pulsoni A; Tosti ME; Annino L; Mele A; Camera A; Martino B; Guglielmi C; Cerri R; Di Bona E; Invernizzi R; Castagnola C; Bassan R; Mele L; Todeschini G; Leone G; Mandelli F
    Br J Haematol; 1999 Sep; 106(4):1037-40. PubMed ID: 10520009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute myeloid leukemia in patients previously diagnosed with breast cancer: experience of the GIMEMA group.
    Pagano L; Pulsoni A; Mele L; Tosti ME; Cerri R; Visani G; Melillo L; Candoni A; Clavio M; Nosari A; Petti MC; Martino B; Mele A; Levis A; Allione B; Almici C; Equitani F; Leone G; Mandelli F;
    Ann Oncol; 2001 Feb; 12(2):203-7. PubMed ID: 11300325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute leukemia following a previous malignancy: do acute lymphoid leukemia and acute myeloid leukemia have common risk factors?
    Pagano L; Pulsoni A; Tosti ME; Mele A; Mele L; Corvatta L; Miraglia E; Almici C; Manna A; Del Poeta G; Lanza F; Masini L; Recchia A; Equitani F; Leone G; Mandelli F;
    Hematol J; 2000; 1(5):329-32. PubMed ID: 11920210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary haematological neoplasm after treatment of adult acute lymphoblastic leukemia: analysis of 1170 adult ALL patients enrolled in the GIMEMA trials. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
    Pagano L; Annino L; Ferrari A; Camera A; Martino B; Montillo M; Tosti ME; Mele A; Pulsoni A; Vegna ML; Leone G; Mandelli F
    Br J Haematol; 1998 Mar; 100(4):669-76. PubMed ID: 9531332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Centre effect on treatment outcome for patients with untreated acute myelogenous leukaemia? An analysis of the AML 8A Study of the Leukemia Cooperative Group of the EORTC and GIMEMA. European Organization for Research and Treatment of Cancer (EORTC) Leukemia Cooperative Group and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA).
    Keating S; de Witte T; Suciu S; Mandelli F; Damasio E; Willemze R; Morra E; Amadori S; Dardenne M; Vegna ML; Zittoun RA
    Eur J Cancer; 1999 Oct; 35(10):1440-7. PubMed ID: 10673975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary acute myeloid leukaemia: results of conventional treatments. Experience of GIMEMA trials.
    Pagano L; Pulsoni A; Vignetti M; Tosti ME; Falcucci P; Fazi P; Fianchi L; Levis A; Bosi A; Angelucci E; Bregni M; Gabbas A; Peta A; Coser P; Ricciuti F; Morselli M; Caira M; Foà R; Amadori S; Mandelli F; Leone G;
    Ann Oncol; 2005 Feb; 16(2):228-33. PubMed ID: 15668275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients.
    Kröger N; Damon L; Zander AR; Wandt H; Derigs G; Ferrante P; Demirer T; Rosti G; ; ;
    Bone Marrow Transplant; 2003 Dec; 32(12):1153-7. PubMed ID: 14647269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensive consolidation therapy compared with standard consolidation and maintenance therapy for adults with acute myeloid leukaemia aged between 46 and 60 years: final results of the randomized phase III study (AML 8B) of the European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups.
    Hengeveld M; Suciu S; Karrasch M; Specchia G; Marie JP; Muus P; Petti MC; Rotoli B; Amadori S; Fioritoni G; Leoni P; Morra E; Thaler J; Resegotti L; Fazi P; Vignetti M; Mandelli F; Zittoun R; de Witte T
    Ann Hematol; 2012 Jun; 91(6):825-35. PubMed ID: 22460947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis of older patients with acute myeloid leukemia receiving either induction or noncurative treatment: a single-center retrospective study.
    Behringer B; Pitako JA; Kunzmann R; Schmoor C; Behringer D; Mertelsmann R; Lübbert M
    Ann Hematol; 2003 Jul; 82(7):381-9. PubMed ID: 12756497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of secondary myeloid malignancy in Hodgkin's disease: the BNLI experience.
    Harrison CN; Vaughan G; Devereux S; Linch DC
    Eur J Haematol; 1998 Aug; 61(2):109-12. PubMed ID: 9714522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity in the therapeutic approach to relapsed elderly patients with acute myeloid leukaemia: a survey from the Gruppo Italiano Malattie Ematologiche dell' Adulto (GIMEMA) Acute Leukaemia Working Party.
    Ferrara F; Fazi P; Venditti A; Pagano L; Amadori S; Mandelli F
    Hematol Oncol; 2008 Jun; 26(2):104-7. PubMed ID: 18271064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of peripheral blood stem cell rescue as intensification in elderly patients with acute myelocytic leukaemia: a pilot study from the Gimema Group. Gruppo Italiano Malattie Ematologiche Maligne Dell'Adulto.
    Montillo M; Tedeschi A; Pagano L; Venditti A; Ferrara F; Fabris P; Martino B; Musso M; De Rosa G; Specchia G; Monaco M; Sparaventi G; Spadea A; Palmas A; Deplano W; Manna A; Melillo L; Miraglia E; Mirto S; Mandelli F
    Br J Haematol; 2000 Oct; 111(1):334-7. PubMed ID: 11091221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study.
    Granfeldt Østgård LS; Medeiros BC; Sengeløv H; Nørgaard M; Andersen MK; Dufva IH; Friis LS; Kjeldsen E; Marcher CW; Preiss B; Severinsen M; Nørgaard JM
    J Clin Oncol; 2015 Nov; 33(31):3641-9. PubMed ID: 26304885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with de novo acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patients.
    Schoch C; Haferlach T; Haase D; Fonatsch C; Löffler H; Schlegelberger B; Staib P; Sauerland MC; Heinecke A; Büchner T; Hiddemann W;
    Br J Haematol; 2001 Jan; 112(1):118-26. PubMed ID: 11167792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and characterization of secondary myelodysplastic syndromes following autologous transplantation.
    Del Cañizo Mf; Amigo Mf; Hernández JM; Sanz G; Núñez R; Carreras E; Alegre A; Cuesta B; Mataix R
    Haematologica; 2000 Apr; 85(4):403-9. PubMed ID: 10756367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of HLA-matched sibling donor availability on treatment outcome for patients with AML: an analysis of the AML 8A study of the EORTC Leukaemia Cooperative Group and GIMEMA. European Organization for Research and Treatment of Cancer. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
    Keating S; de Witte T; Suciu S; Willemze R; Hayat M; Labar B; Resegotti L; Ferrini PR; Caronia F; Dardenne M; Solbu G; Petti MC; Vegna ML; Mandelli F; Zittoun RA
    Br J Haematol; 1998 Sep; 102(5):1344-53. PubMed ID: 9753069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors of patients with acute myeloid leukemia (AML) allografted in first complete remission: an analysis of the EORTC-GIMEMA AML 8A trial. The European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto (GIMEMA) Leukemia Cooperative Groups.
    Keating S; Suciu S; de Witte T; Mandelli F; Willemze R; Resegotti L; Broccia G; Thaler J; Labar B; Damasio E; Bizzi B; Rotoli B; Vekhoff A; Muus P; Petti MC; Dardenne M; Solbu G; Vegna ML; Zittoun RA
    Bone Marrow Transplant; 1996 Jun; 17(6):993-1001. PubMed ID: 8807105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute myeloid leukemia as a second malignancy: report of 9 pediatric patients in a single institution in Argentina.
    Felice MS; Zubizarreta PA; Chantada GL; Alfaro E; Cygler AM; Gallego M; Rossi J; Sackmann-Muriel F
    Med Pediatr Oncol; 1998 Mar; 30(3):160-4. PubMed ID: 9434824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence of secondary leukemias.
    Leone G; Mele L; Pulsoni A; Equitani F; Pagano L
    Haematologica; 1999 Oct; 84(10):937-45. PubMed ID: 10509043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.